Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bausch + Lomb Co. stock logo
BLCO
Bausch + Lomb
$14.90
+0.3%
$15.93
$13.62
$21.95
$5.24B0.36477,253 shs321,955 shs
National Vision Holdings, Inc. stock logo
EYE
National Vision
$17.73
-5.9%
$21.27
$13.71
$27.02
$1.48B1.39964,088 shs1.09 million shs
RxSight, Inc. stock logo
RXST
RxSight
$52.84
-3.8%
$52.66
$17.09
$58.21
$1.95B1.22430,113 shs288,150 shs
STAAR Surgical stock logo
STAA
STAAR Surgical
$47.82
-0.8%
$38.87
$26.66
$73.13
$2.34B0.86755,067 shs571,217 shs
Warby Parker Inc. stock logo
WRBY
Warby Parker
$13.08
-2.4%
$13.01
$9.83
$16.49
$1.29B1.631.20 million shs1.31 million shs
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bausch + Lomb Co. stock logo
BLCO
Bausch + Lomb
+0.34%+4.12%-10.32%+3.08%-10.56%
National Vision Holdings, Inc. stock logo
EYE
National Vision
-5.89%-6.59%-17.88%-5.69%-13.51%
RxSight, Inc. stock logo
RXST
RxSight
-3.79%+0.02%+7.86%+11.85%+204.20%
STAAR Surgical stock logo
STAA
STAAR Surgical
-0.77%+3.19%+28.62%+61.17%-29.99%
Warby Parker Inc. stock logo
WRBY
Warby Parker
-2.39%+8.10%+1.08%-1.06%+26.38%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bausch + Lomb Co. stock logo
BLCO
Bausch + Lomb
3.5243 of 5 stars
4.33.00.00.02.20.02.5
National Vision Holdings, Inc. stock logo
EYE
National Vision
3.6535 of 5 stars
3.02.00.03.32.80.01.9
RxSight, Inc. stock logo
RXST
RxSight
1.8786 of 5 stars
1.54.00.00.02.85.00.6
STAAR Surgical stock logo
STAA
STAAR Surgical
4.4562 of 5 stars
2.22.00.04.13.13.33.1
Warby Parker Inc. stock logo
WRBY
Warby Parker
1.129 of 5 stars
2.21.00.00.02.34.20.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bausch + Lomb Co. stock logo
BLCO
Bausch + Lomb
2.50
Moderate Buy$19.5030.87% Upside
National Vision Holdings, Inc. stock logo
EYE
National Vision
2.00
Hold$23.8634.56% Upside
RxSight, Inc. stock logo
RXST
RxSight
3.00
Buy$49.63-6.08% Downside
STAAR Surgical stock logo
STAA
STAAR Surgical
2.40
Hold$46.38-3.02% Downside
Warby Parker Inc. stock logo
WRBY
Warby Parker
2.38
Hold$16.2924.51% Upside

Current Analyst Ratings

Latest STAA, EYE, BLCO, WRBY, and RXST Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/22/2024
Bausch + Lomb Co. stock logo
BLCO
Bausch + Lomb
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$20.00 ➝ $18.00
4/11/2024
RxSight, Inc. stock logo
RXST
RxSight
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$64.00
4/11/2024
STAAR Surgical stock logo
STAA
STAAR Surgical
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$45.00 ➝ $53.00
4/8/2024
STAAR Surgical stock logo
STAA
STAAR Surgical
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$32.00 ➝ $46.00
4/4/2024
Bausch + Lomb Co. stock logo
BLCO
Bausch + Lomb
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$16.50 ➝ $17.00
4/4/2024
STAAR Surgical stock logo
STAA
STAAR Surgical
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform
4/4/2024
STAAR Surgical stock logo
STAA
STAAR Surgical
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
4/1/2024
STAAR Surgical stock logo
STAA
STAAR Surgical
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$50.00
3/11/2024
STAAR Surgical stock logo
STAA
STAAR Surgical
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$30.00 ➝ $50.00
2/29/2024
RxSight, Inc. stock logo
RXST
RxSight
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$54.00 ➝ $64.00
2/29/2024
RxSight, Inc. stock logo
RXST
RxSight
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$40.00 ➝ $62.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bausch + Lomb Co. stock logo
BLCO
Bausch + Lomb
$4.15B1.26$1.94 per share7.67$19.72 per share0.76
National Vision Holdings, Inc. stock logo
EYE
National Vision
$2.13B0.65$1.69 per share10.48$10.60 per share1.67
RxSight, Inc. stock logo
RXST
RxSight
$89.08M21.94N/AN/A$4.47 per share11.82
STAAR Surgical stock logo
STAA
STAAR Surgical
$322.42M7.25$0.75 per share63.60$7.91 per share6.05
Warby Parker Inc. stock logo
WRBY
Warby Parker
$669.77M1.92N/AN/A$3.08 per share4.25

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bausch + Lomb Co. stock logo
BLCO
Bausch + Lomb
-$260M-$0.74N/A16.931.41-6.27%3.70%2.11%5/1/2024 (Confirmed)
National Vision Holdings, Inc. stock logo
EYE
National Vision
-$65.90M-$0.85N/A37.724.15-3.10%3.69%1.41%5/9/2024 (Estimated)
RxSight, Inc. stock logo
RXST
RxSight
-$48.61M-$1.43N/AN/AN/A-54.57%-31.16%-25.51%5/6/2024 (Confirmed)
STAAR Surgical stock logo
STAA
STAAR Surgical
$21.35M$0.43111.2193.76N/A6.62%8.73%6.99%5/1/2024 (Estimated)
Warby Parker Inc. stock logo
WRBY
Warby Parker
-$63.20M-$0.54N/A327.00N/A-9.44%-16.36%-8.66%5/9/2024 (Confirmed)

Latest STAA, EYE, BLCO, WRBY, and RXST Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024N/A
Warby Parker Inc. stock logo
WRBY
Warby Parker
$0.07N/A-$0.07N/AN/AN/A  
5/6/2024N/A
RxSight, Inc. stock logo
RXST
RxSight
-$0.1680N/A+$0.1680N/AN/AN/A  
5/1/2024N/A
Bausch + Lomb Co. stock logo
BLCO
Bausch + Lomb
$0.09N/A-$0.09N/AN/AN/A  
2/28/2024Q4 2023
RxSight, Inc. stock logo
RXST
RxSight
-$0.36-$0.26+$0.10-$0.26$28.60 million$28.58 million    
2/28/2024Q4 2023
Warby Parker Inc. stock logo
WRBY
Warby Parker
-$0.11-$0.15-$0.04-$0.14$161.01 million$161.86 million    
2/27/202412/31/2023
National Vision Holdings, Inc. stock logo
EYE
National Vision
-$0.09-$0.02+$0.07$0.06$499.49 million$506.40 million      
2/26/2024Q4 23
STAAR Surgical stock logo
STAA
STAAR Surgical
$0.17$0.16-$0.01$0.32$75.94 million$76.27 million    
2/21/202412/31/2023
Bausch + Lomb Co. stock logo
BLCO
Bausch + Lomb
$0.17$0.24+$0.07$0.63$1.11 billion$1.17 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bausch + Lomb Co. stock logo
BLCO
Bausch + Lomb
N/AN/AN/AN/AN/A
National Vision Holdings, Inc. stock logo
EYE
National Vision
N/AN/AN/AN/AN/A
RxSight, Inc. stock logo
RXST
RxSight
N/AN/AN/AN/AN/A
STAAR Surgical stock logo
STAA
STAAR Surgical
N/AN/AN/AN/AN/A
Warby Parker Inc. stock logo
WRBY
Warby Parker
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bausch + Lomb Co. stock logo
BLCO
Bausch + Lomb
0.65
1.74
1.09
National Vision Holdings, Inc. stock logo
EYE
National Vision
0.54
1.00
0.70
RxSight, Inc. stock logo
RXST
RxSight
N/A
8.06
7.22
STAAR Surgical stock logo
STAA
STAAR Surgical
N/A
5.62
5.08
Warby Parker Inc. stock logo
WRBY
Warby Parker
N/A
2.35
1.86

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Bausch + Lomb Co. stock logo
BLCO
Bausch + Lomb
11.07%
National Vision Holdings, Inc. stock logo
EYE
National Vision
N/A
RxSight, Inc. stock logo
RXST
RxSight
78.78%
STAAR Surgical stock logo
STAA
STAAR Surgical
96.70%
Warby Parker Inc. stock logo
WRBY
Warby Parker
93.24%

Insider Ownership

CompanyInsider Ownership
Bausch + Lomb Co. stock logo
BLCO
Bausch + Lomb
N/A
National Vision Holdings, Inc. stock logo
EYE
National Vision
2.10%
RxSight, Inc. stock logo
RXST
RxSight
21.13%
STAAR Surgical stock logo
STAA
STAAR Surgical
1.10%
Warby Parker Inc. stock logo
WRBY
Warby Parker
26.91%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Bausch + Lomb Co. stock logo
BLCO
Bausch + Lomb
13,300351.40 millionN/AOptionable
National Vision Holdings, Inc. stock logo
EYE
National Vision
13,99878.31 million76.67 millionOptionable
RxSight, Inc. stock logo
RXST
RxSight
37436.99 million29.17 millionOptionable
STAAR Surgical stock logo
STAA
STAAR Surgical
1,11548.87 million48.33 millionOptionable
Warby Parker Inc. stock logo
WRBY
Warby Parker
2,14098.37 million71.90 millionOptionable

STAA, EYE, BLCO, WRBY, and RXST Headlines

SourceHeadline
Glasses retailer Warby Parker to open at Mayfaire Town CenterGlasses retailer Warby Parker to open at Mayfaire Town Center
msn.com - April 23 at 8:11 PM
Warby Parker (NYSE:WRBY) Stock Price Up 7.8%Warby Parker (NYSE:WRBY) Stock Price Up 7.8%
marketbeat.com - April 23 at 3:44 PM
Warby Parker and these 5 other new stores are coming to Battlefield MallWarby Parker and these 5 other new stores are coming to Battlefield Mall
msn.com - April 20 at 9:48 AM
Warby Parker to Announce First Quarter 2024 Financial Results on May 9, 2024Warby Parker to Announce First Quarter 2024 Financial Results on May 9, 2024
businesswire.com - April 18 at 4:05 PM
Alvarez & Marsal Property Solutions Brings on Retail Real Estate Veteran Rebecca Fitts as Senior Vice PresidentAlvarez & Marsal Property Solutions Brings on Retail Real Estate Veteran Rebecca Fitts as Senior Vice President
finance.yahoo.com - April 17 at 5:31 PM
Warby Parker Publishes 2023 Impact ReportWarby Parker Publishes 2023 Impact Report
finance.yahoo.com - April 17 at 12:29 PM
Warby Parker Publishes 2023 Impact ReportWarby Parker Publishes 2023 Impact Report
businesswire.com - April 17 at 9:00 AM
Popular eye care brand to open soon in Wilmington. Heres what to know.Popular eye care brand to open soon in Wilmington. Here's what to know.
msn.com - April 16 at 4:28 PM
‘Warby Parker’ opening new store in Mayfaire‘Warby Parker’ opening new store in Mayfaire
wwaytv3.com - April 16 at 4:28 PM
Warby Parker saw a surge in brand interest around the lunar eclipseWarby Parker saw a surge in brand interest around the lunar eclipse
msn.com - April 15 at 8:12 AM
Warby Parker Inc. (NYSE:WRBY) Receives Average Rating of "Hold" from AnalystsWarby Parker Inc. (NYSE:WRBY) Receives Average Rating of "Hold" from Analysts
marketbeat.com - April 12 at 2:33 AM
Heres how to donate solar eclipse glasses now that you no longer need themHere's how to donate solar eclipse glasses now that you no longer need them
msn.com - April 10 at 12:53 PM
Baillie Gifford & Co. Boosts Holdings in Warby Parker Inc. (NYSE:WRBY)Baillie Gifford & Co. Boosts Holdings in Warby Parker Inc. (NYSE:WRBY)
marketbeat.com - April 10 at 8:34 AM
Warby Parker giving out free eclipse glassesWarby Parker giving out free eclipse glasses
wtsp.com - April 10 at 1:57 AM
Warby Parker collecting old eclipse glasses to give to othersWarby Parker collecting old eclipse glasses to give to others
wnyt.com - April 10 at 1:57 AM
Billion Dollar Brand Warby Parker Turned The Total Eclipse Into A Marketing MasterclassBillion Dollar Brand Warby Parker Turned The Total Eclipse Into A Marketing Masterclass
forbes.com - April 8 at 8:40 PM
April 8 - Warby Parker opens first Savannah locationApril 8 - Warby Parker opens first Savannah location
savannahbusinessjournal.com - April 8 at 5:39 AM
Solar eclipse mania: Warby Parker, Burger King, Krispy Kreme offer exclusive products, dealsSolar eclipse mania: Warby Parker, Burger King, Krispy Kreme offer exclusive products, deals
msn.com - April 5 at 10:56 AM
Warby Parker Inc. (NYSE:WRBY) Shares Acquired by Vanguard Group Inc.Warby Parker Inc. (NYSE:WRBY) Shares Acquired by Vanguard Group Inc.
marketbeat.com - April 5 at 4:07 AM
Warby Parker now offering free eclipse glasses. Heres when and where to get them in FloridaWarby Parker now offering free eclipse glasses. Here's when and where to get them in Florida
msn.com - April 3 at 10:24 AM
Warby Parker is offering free glasses ahead of total solar eclipse: How to get themWarby Parker is offering free glasses ahead of total solar eclipse: How to get them
msn.com - April 2 at 1:45 AM
Warby Parker Solar Eclipse Glasses free giveaway starting April 1Warby Parker Solar Eclipse Glasses free giveaway starting April 1
fox26houston.com - April 1 at 8:45 PM
Warby Parker Collaborates on Sunglasses Inspired by Theophilio’s Childhood in JamaicaWarby Parker Collaborates on Sunglasses Inspired by Theophilio’s Childhood in Jamaica
wwd.com - March 20 at 6:52 PM
Warby Parker: Positive Outlook Ahead With Margin ExpansionWarby Parker: Positive Outlook Ahead With Margin Expansion
seekingalpha.com - March 20 at 4:47 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Bausch + Lomb logo

Bausch + Lomb

NYSE:BLCO
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. Its Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation is a subsidiary of Bausch Health Companies Inc.
National Vision logo

National Vision

NASDAQ:EYE
National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.
RxSight logo

RxSight

NASDAQ:RXST
RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
STAAR Surgical logo

STAAR Surgical

NASDAQ:STAA
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Warby Parker logo

Warby Parker

NYSE:WRBY
Warby Parker Inc. provides eyewear products in the United States and Canada. The company offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, non-prescription lenses, and contact lenses. It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray through its retail stores, website, and mobile apps. In addition, the company offers eye exams and vision tests. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.